Karyopharm Therapeutics Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0001104659-13-081324 | Nov 5, 2013 | — |
| 3 | 3 | 0001104659-13-081323 | Nov 5, 2013 | — |
| 3 | 3 | 0001104659-13-081322 | Nov 5, 2013 | — |
| 3 | 3 | 0001104659-13-081321 | Nov 5, 2013 | — |
| 3 | 3 | 0001104659-13-081320 | Nov 5, 2013 | — |
| 3 | 3 | 0001104659-13-081319 | Nov 5, 2013 | — |
| S-1MEF | S-1MEF | 0001047469-13-010286 | Nov 5, 2013 | — |
| UPLOAD | — | 0000000000-13-060615 | Nov 5, 2013 | — |
| CORRESP | — | 0001104659-13-080544 | Nov 4, 2013 | — |
| CORRESP | — | 0001104659-13-080012 | Nov 1, 2013 | — |
| CORRESP | — | 0001104659-13-080011 | Nov 1, 2013 | — |
| 8-A12B | 8-A12B | 0001104659-13-079966 | Nov 1, 2013 | — |
| S-1/A | S-1/A | 0001047469-13-009972 | Oct 28, 2013 | — |
| UPLOAD | — | 0000000000-13-058646 | Oct 24, 2013 | — |
| CORRESP | — | 0001104659-13-076316 | Oct 18, 2013 | — |
| S-1 | S-1 | 0001047469-13-009519 | Oct 4, 2013 | — |
| UPLOAD | — | 0000000000-13-054592 | Oct 3, 2013 | — |
| DRSLTR | — | 0001410578-13-000213 | Sep 5, 2013 | — |
| DRS | — | 0000912057-13-000295 | Sep 5, 2013 | — |
| D | — | 0001503802-13-000004 | Aug 1, 2013 | — |
| D | — | 0001503802-13-000003 | May 1, 2013 | — |
| D | — | 0001503802-10-000001 | Nov 5, 2010 | — |